Chimerix holds the potential to have the first approval of dordaviprone for treating recurrent H3 K27M mutant high-grade ...

The FDA has granted a priority review to dordaviprone for treating patients with recurrent H3K27M-mutant diffuse glioma, a ...

In a Phase III trial, 28 percent of newly diagnosed patients with H3 K27M-mutant diffuse glioma responded to treatment with dordaviprone.

Shares of Chimerix hit a new 52-week high Tuesday after the biopharmaceutical company said the Food and Drug Administration granted a priority review for its proposed dordaviprone treatment for a ...

Shares of Chimerix (NASDAQ: NASDAQ: CMRX) climbed 12.5% as the company announced the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for dordaviprone, a potential ...

Interrupting signals exchanged between tumors and the nervous system could become a critical pillar of cancer care ...

The following is a summary of "Periventricular gliomas. Evaluation of the risks associated with ventricular opening in two ...

A 6-year-old boy died after he was diagnosed with glioma, a deadly brain tumour that doubled his weight in a short span.

A schoolboy died from a deadly brain tumor after his weight doubled in 16 months. Luke Poga’s mum Sam, 42, initially attributed the nine-year-old’s rapid weight gain to a lack of exercise during the ...

In this video, Annick Desjardins, MD, professor of neurosurgery, professor of neurology and member of the Duke Cancer Institute, explains how clinicians may treat patients with gliomas of different ...

A SCHOOLBOY died from a deadly form of cancer after a “noticeable change” in his appearance. Luke Poga’s weight doubled in 16 ...

A schoolboy died from a deadly brain tumour after his weight doubled in 16 months. Luke Poga's mum Sam, 42, initially ...